Ultrasound evaluation of fetal gender at weeks
|
|
|
- Osborn Strickland
- 9 years ago
- Views:
Transcription
1 Ultrasound evaluation of fetal gender at weeks Marek Lubusky a,b, Martina Studnickova a, Ales Skrivanek a, Katherine Vomackova c, Martin Prochazka a Aims. The aim of this study was to assess the feasibility and accuracy of fetal gender assignment by transabdominal ultrasound at weeks of gestation. Methods. Fetal gender assessment was performed in 1222 singleton pregnancies. In all fetuses the crown rump length () was measured and the genital area of the fetus was examined in the mid sagittal plane. The result of ultrasound examination was compared to the phenotypic sex of the newborn after delivery. Results. The feasibility as well as accuracy in determining gender increased with growing fetal. At < 50 mm (gestational age < 11+4) the feasibility was 39.1% and accuracy 30.5% (40.9% in male gender vs 24.3% in female gender). At mm (gestational age 11+4 to 12+0) the feasibility was 63.5% and accuracy 75.0% (89.1% in male gender vs 66.7% in female gender). At mm (gestational age 12+0 to 12+2) the feasibility was 90.5% and accuracy 96.6% (99.1% in male gender vs 93.5% in female gender). At 60 mm (gestational age 12+2) the feasibility was 97.4% and accuracy.0% (.0% in male gender vs.0% in female gender). Conclusions. Fetal gender may reliably be determined when 60 mm (gestational age 12+2). Male gender may already be reliably determined when 55 mm (gestational age 12+0). If < 50 mm (gestational age < 11+4) the gender cannot be reliably predicted. Key words: fetal gender, fetal sex, first trimester, ultrasonography Received: August 27, 2011; Accepted with revision: February 14, 2012; Available online: April 19, a Department of Obstetrics and Gynecology, University Hospital Olomouc, Czech Republic b Department of Medical Genetics and Fetal Medicine, University Hospital Olomouc c Department of Surgery I, University Hospital Olomouc Corresponding author: Marek Lubusky, [email protected] INTRODUCTION During screening for Down syndrome in the I. trimester of pregnancy, parameters with values dependent on fetal gender (fetal nuchal translucency measured by ultrasound, free β hcg and PAPP A levels in maternal serum) are evaluated when calculating individual risk of incidence of trisomy in the fetus 1 4. Reliable non invasive determination of fetal gender in the monitored time period could enable modification of normal values of these parameters based on fetal gender and make the algorithm for calculating individual risk more accurate. A more accurate calculation of the "individual risk" of incidence of trisomy in the fetus could lead to a decrease in the number of invasive procedures (chorionic villus sampling, amniocentesis) indicated to determine the karyotype of the fetus and thus minimalize possible fetal complications associated with these examinations. Also, it would not be necessary to perform invasive procedures if there was suspicion of sex linked genetic disease of the fetus 5 7. Information about fetal gender is currently not used in clinical practice for the correction of calculation of individual risk for fetal trisomy. In contrast, if there is suspicion of sex linked genetic diseases, reliable information about fetal gender already plays a significant role in current clinical practice. To date, only a few studies regarding fetal gender assignment in early pregnancy by ultrasound have been published, and these are usually of an older date and describe only a small sample of patients The aim of this study was to assess the feasibility and accuracy of fetal gender assignment by transabdominal ultrasound at weeks of gestation, during which combined screening for the most common fetal chromosomal anomalies is performed. MATERIALS AND METHODS Ultrasound examination aimed at determining fetal gender was performed during the first trimester of pregnancy at weeks (, mm). All examinations were performed by one examiner (M.L.). From January 2005 to February 2010, a total of 1222 fetuses were examined, all were from a single pregnancy without established morphological or chromosomal abnormalities in the fetus or newborn. All the scans were performed transabdominally using 5 MHz transducers (GE Voluson E8 Expert ; GE Voluson 730 Expert, GE Healthcare Technologies, Zipf, Austria). The crown rump length () was measured in all fetuses. The genital area of the fetus was examined in the mid sagittal plane, in the neutral position of the fetus (without the presence of hyperflexion or hyperextension). When determining fetal gender, the method described by Efrat et al. 13 was 1
2 used. The angle between the genital tubercle axis and a horizontal line through the lumbosacral skin surface was measured. Angles >30 established the gender to be male (Fig. 1), if the axis of the genital tubercle ran parallel (<10 ) or convergent to the horizontal line, gender was established as female (Fig. 2), if the angle was intermediate (10 30 ) gender was not determined. The result of ultrasound examination was compared to the phenotypic sex of the newborn after delivery. Statistical analysis was performed using the χ2 test, or Fisher s exact test when appropriate. Values of P < 0.05 were considered statistically significant. RESULTS The possibility of determining fetal gender during ultrasound examination based on the crown rump length () is presented in Table 1, 2. It was possible to establish gender in 1025 of a total of 1222 fetuses (84%). In 197 fetuses (16%) it was not possible to determine gender during ultrasound examination. The most common cause was an intermediate angle (10 30 ) between genital tubercle axis and the horizontal line (78%), followed by unfavorable fetal position (12%) and maternal habitus (10%). In 51 of 1025 fetuses (5%) it was not possible to perform a comparison of gender assignment by ultrasound examination with phenotypic sex of the newborn after delivery. In the remaining 974 fetuses, gender was correctly established in 92.5% of cases (901/974), male gender in 96.3% (471/489), female gender in 88.7% (430/485) (Table 3). The feasibility and accuracy in determining gender during ultrasound examination increased with growing crown rump length () of the fetus (Table 2, 3, 4, 5, 6). The difference between male and female gender was not statistically significant. The feasibility of gender determination during ultrasound examination was 39% at mm, 64% at mm, 90% at mm and 97.4% at mm. The difference was statistically significant (P=0.012 for mm vs mm, P=0.021 for mm vs mm, and P< for mm vs mm) The accuracy in determining male gender was 41% at mm, 89% at mm, 99% at mm and % at mm. The difference was statistically significant (P=0.023 for mm vs mm). The accuracy in determining female gender was 24% at mm, 67% at mm, 94% at mm and % at mm. The difference was statistically significant (P=0.014 for mm vs mm, P= for mm vs mm, P= for mm vs mm, and P=0.015 for mm vs mm). At < 50 mm (gestational age < 11+4) feasibility was 39.1% and accuracy 30.5% (40.9% in male gender vs 24.3% in female gender). At mm (gestational age 11+4 to 12+0) the feasibility was 63.5% and accuracy 75.0% (89.1% in male gender vs 66.7% in female gender). At mm (gestational age 12+0 to 12+2) the feasibility was 90.5% and accuracy 96.6% (99.1% in male gender vs 93.5% in female gender). At 60 mm (gestational age 12+2) the feasibility was 97.4% and accuracy.0% (.0% in male gender vs.0% in female gender). DISCUSSION According to our results, it was possible to reliably determine the fetal gender by transabdominal ultrasound (feasibility 97.4%, accuracy %) at 60 mm (gestational age 12+2). At 55 mm (gestational age 12+0) the feasibility was 95.5% and accuracy 99.1% (99.8% in male gender vs 98.4% in female gender). At Fig. 1. Ultrasound examination established gender to be male if the angle between the genital tubercle axis and a horizontal line through the lumbosacral skin surface was >30. Fig. 2. Ultrasound examination established gender to be female if the axis of the genital tubercle ran parallel (<10 ) or convergent to the horizontal line. 2
3 Table 1. Gender identification at ultrasound examination according to crown rump length (). Patients Gender indetified by ultrasound Gender verified Lost to follow up (n) (n) (n) (n) to to to to to to to to Total Table 2. Gender feasibility by ultrasound according to crown rump lenght (). Feasibility to , to , to , to , to , to , to , to ,8 Table 3. Accuracy of sonographic fetal gender assignment according to crown rump length. Total accuracy Male accuracy Female accuracy (n) (n) (n) to / / / to / 75 33/ / to / / / to / / / to / / / to /56 29/29 27/ to /41 18/18 23/ to /20 12/12 8/8 Total 901/ / /
4 Table 4. Total accuracy of sonographic fetal gender assignment according to crown rump length. Total accuracy to to to to to to to to 13+6 Table 5. Male accuracy of sonographic fetal gender assignment accoridng to crown rump length. Male accuracy to to to to to to to to 13+6 Table 6. Female accuracy of sonographic fetal gender assignment accoridng to crown rump length. Female accuracy to to to to to to to to
5 50 mm (gestational age 11+4) the feasibility was 90.4% and accuracy 96.5% (98.9% in male gender vs 94.0% in female gender). At 45 mm (gestational age 11+1) the feasibility was 83.9% and accuracy 92.5% (96% in male gender vs 88.7% in female gender). Efrat et al. 13 describe the feasibility of determining fetal gender using transabdominal ultrasound as 92.6% ( 55.4 mm; n=656), Chelli et al % ( 45 mm; n=312), Hsiao et al. 11 report the feasibility as 88.9% ( 45 mm; n=496) and 96% ( 57 mm; n=400), Mazza et al % (BPD mm; n=385). In the last two studies, however, the same method was not used to determine gender and in the last study a different biometric parameter was used (BPD; biparietal diameter of the head). It is also difficult to compare the results due to the small sample size of patients as well as the improved imaging of new ultrasound devices. Efrat et al. 13 present the accuracy of determining fetal gender to be 98.5% ( 55.4 mm), 99.6% in male gender vs 97.4% in female gender. Chelli et al. 10 describe at 45 mm an accuracy of 85.7% (in male gender 87.9% vs 83.3% in female gender). Hsiao et al. 11 report an accuracy of 91.8% ( 45 mm), 92.5% in male gender vs 91.2% in female gender. Mazza et al. 14 at BPD mm describe an acucuracy of 87.5% (male gender 91.5% vs 95.9% female gender) and at BPD 23 mm report an accuracy of %. At < 50 mm (gestational age < 11+4) fetal gender assignment by transabdominal ultrasound in our patient set was possible in only 39% of fetuses (61/156). In most cases gender was determined to be female (63%). The assignment accuracy was in indirect proportion between the sexes, male gender was successfully determined in 41% of cases (9/22) and female in only 24% of cases (9/37). Therefore in total, reliable gender assignment was possible in only 11.7% (18/154) of the examined fetuses. Efrat et al. 12 at mm present reliability of gender assignment to be 92.5% (37/40) and accuracy to be 70.2% (26/37), 44.4% in male gender assignment (8/18) vs 94.7% in female gender assignment (18/19). However, this study used a different method for determining fetal gender and a different was evaluated. At a similar of mm the feasibility of gender determination in our set was 51.8% (169/326) and accuracy was 58.5% (93/159), 71.2% in male gender assignment (42/59) vs 51.0% in female gender assignment (51/). Pedreira et al. 21 described a change in the orientation of the genital tubercle during examination ( mm) on a set of 11 fetuses (6 fetuses of male gender and 5 fetuses of female gender). Determination of fetal gender in the first trimester of pregnancy by transabdominal ultrasound necessitates considerable erudition of the examiner and a sufficient timeframe for the examination, because the most difficult as well as most important is the imaging of the fetus in the required reference plane. According to our results, at < 50 mm (gestational age < 11+4) the fetal gender cannot be reliably predicted using this method. Cowans et al. 1 demonstrated the significant influence of fetal gender on values of nuchal translucency (delta NT) and level of free ß hcg and PAPP A in maternal serum during screening for chromosomal aneuploidies in the first trimester on a set of normal singleton pregnancies and in 722 pregnancies where the fetus had trisomy 21. Normal female fetuses had levels of nuchal translucency (delta NT) which were 9.4% lower, and maternal serum levels of free ß hcg and PAPP A were higher (by 14.7% and 6.3% respectively) compared to fetuses of male gender. Female fetuses with trisomy 21 had 12% lower values of nuchal translucency (delta NT) and higher levels of free ß hcg (by 20.8%) and PAPP A (by 5.7%). Larsen et al. 3 describe higher levels of free ß hcg (by 15%) as well as PAPP A (by 7%) in maternal serum in cases of female fetuses in a set of 2637 normal single pregnancies. Lam et al. 2 on a set of pregnancies between week presented 5% lower values of nuchal translucency (delta NT) in fetuses of female gender. Reliable determination of fetal gender by transabdominal ultrasound in week of gestation could serve as an additional marker to allow for more accurate calculation of the individual risk of incidence of trisomy 21 in the fetus. Fetal gender may also be determined non invasively in the first trimester by analyzing free fetal DNA obtained from the plasma of maternal peripheral blood. The method allows assignment of genotypic sex of the fetus and sensitivity and specificity of this method is nearly % (ref. 5 ). During ultrasound examination, only the phenotypic sex of the fetus may be assessed, which may differ from genotypic sex (testicular feminization, severe hypospadia, etc.). However, ultrasound examination is less invasive, less expensive and easily feasible. The possibility of reliably and non invasively determining fetal gender already in the first trimester, however, incurs the risk of misuse of fetal gender selection for non medical purposes. CONCLUSIONS Fetal gender may reliably be determined by transabdominal ultrasound when 60 mm (gestational age 12+2). Male gender may already be reliably determined when 55 mm (gestational age 12+0). If < 50 mm (gestational age < 11+4) gender cannot be reliably predicted. It is always necessary to take into account the maternal habitus, the position of the fetus and the imaging possibilities of the ultrasound device. The experience and erudition of the examiner are very important. ABBREVATIONS BPD, Biparietal diameter;, Crown rump length; hcg, Human chorionic gonadotropin; NT, Nuchal translucency; PAPP A, Pregnancy associated plasma protein A. 5
6 ACKNOWLEDGEMENTS Supported by the grants from the Ministry of Health of the Czech Republic IGA NS /2009, NT 14 3/2010, NT /2011. REFERENCES 1. Cowans NJ, Stamatopoulou A, Maiz N, Spencer K, Nicolaides KH. The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta hcg and PAPP A MoM in normal and trisomy 21 pregnancies. Prenat Diagn 2009;29: Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of fetal gender on nuchal translucency at weeks of gestation. Prenat Diagn 2001;21: Larsen SO, Wøjdemann KR, Shalmi AC, Sundberg K, Christianses M, Tabor A. Gender impact on first trimester markers in Down syndrome screening. Prenat Diagn 2002;22: Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta hcg and PAPP A at weeks of gestation. Prenat Diagn 2000;20: Finning KM, Chitty LS. Non invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2008;13: Hyett JA, Gardener G, Stojilkovic Mikic T, Finning KM, Martin PG, Rodeck CH, Chitty LS. Reduction in diagnostic and therapeutic interventions by non invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005;25: Mazza V, Falcinelli C, Percesepe A, Paganelli S, Volpe A, Forabosco A. Non invasive first trimester fetal gender assignment in pregnancies at risk for X linked recessive diseases. Prenat Diagn 2002;22: Benoit B. Early fetal gender determination [opinion]. Utrasound Obstet Gynecol 1999;13: Bronsthein M, Rottem S, Yoffe N, Blumenfeld Z, Brandes JM. Early determination of fetal sex using transvaginal sonography: technique and pitfalls. J Clin Ultrasound 1990;18: Chelli D, Methni A, Dimassi K, Boudaya F, Sfar E, Zouaoui B, Chelli H, Chennoufi MB. Fetal sex assignment by first trimester ultrasound: a Tunisian experience. Prenat Diagn 2009;29: Hsiao CH, Wang HC, Hsieh CF, Hsu JJ. Fetal gender screening by ultrasound at 11 to 13+6 weeks. Acta Obstet Gynecol Scand 2008;87: Efrat Z, Akinfenwa OO, Nicolaides KH. First trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol 1999;13: Efrat Z, Perri T, Ramati E, Tugendreich D, Meizner I. Fetal gender assignement by first trimester ultrasound. Ultrasound Obstet Gynecol 2006;27: Mazza V, Contu G, Falcinelli C, Battafarano S, Cagnacci A, Vito G, Forabosco A, Volpe A. Biometrical threshold of biparietal diameter for certain fetal sex assignment by ultrasound. Ultrasound Obstet Gynecol 1999;13: Mazza V, Falcinelli C, Paganelli S, Contu G, Mantuano SM, Battafarano SD, Forabosco A, Volpe A. Sonographic early fetal gender assignment: a longitudinal study in pregnancies after in vitro fertilization. Ultrasound Obstet Gynecol 2001;17: Mazza V, Di Monte I, Pati M, Contu G, Ottolenghi C, Forabosco A, Volpe A. Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases. Prenat Diagn 2004;24: Michailidis GD, Papageorgiou P, Morris RW, Economides DL. The use of three dimensional ultrasound for fetal gender determination in the first trimester. Br J Radiol 2003;76: Mielke G, Kiesel L, Backsch C, Erz W, Gonser M. Fetal sex determination by high resolution ultrasound in early pregnancy. Eur J Ultrasound 1998;7: Pedreira DA. In search for the 'third point' [comment]. Ultrasound Obstet Gynecol 2000;15: Whitlow BJ, Lazanakis MS, Economides DL. The sonographic identification of fetal gender from 11 to 14 weeks of gestation. Ultrasound Obstet Gynecol 1999;13: Pedreira DA, Yamasaki A, Czeresnia CE. Fetal Phallus 'errection' interfering with the sonographic determination of fetal gender in the first trimester. Ultrasound Obstet Gynecol 2001;18:
Clinical Studies Abstract Booklet
Clinical Studies Abstract Booklet The Harmony Prenatal Test is a non-invasive prenatal test (NIPT) that assesses the risk of trisomies by analyzing cell-free DNA (cfdna) in maternal blood. Since January
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hcg and PAPP-A at 11 + 0to13+ 6 weeks
Ultrasound Obstet Gynecol 2006; 27: 151 155 Published online 30 December 2005 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.2699 Screening for trisomy 21 by fetal tricuspid regurgitation,
Screening for chromosomal abnormalities at 10 14 weeks: the role of ductus venosus blood flow
Ultrasound Obstet Gynecol 1998;12:380 384 Screening for chromosomal abnormalities at 10 14 weeks: the role of ductus venosus blood flow A. Matias*, C. Gomes*, N. Flack*, N. Montenegro and K. H. Nicolaides*
your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing.
your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing. Accurate answers about your baby s health simply, safely, sooner. What is the verifi Prenatal
Sonographic screening for trisomy 13 at 11 to 13 D6 weeks of gestation
American Journal of Obstetrics and Gynecology (2006) 194, 397 401 www.ajog.org Sonographic screening for trisomy 13 at 11 to 13 D6 weeks of gestation Aris T. Papageorghiou, MD, a Kyriaki Avgidou, MD, a
Frontomaxillary and mandibulomaxillary facial angles at 11 + 0to13+ 6 weeks in fetuses with trisomy 18
Ultrasound Obstet Gynecol 2007; 30: 928 933 Published online 1 November 2007 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.2/uog.5188 Frontomaxillary and mandibulomaxillary facial angles
A test your patients can trust.
A test your patients can trust. A simple, safe, and accurate non-invasive prenatal test for early risk assessment of Down syndrome and other conditions. informaseq Prenatal Test Simple, safe, and accurate
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns
cfdna in maternal plasma obtained from a population undergoing routine screening at 11-13 weeks gestation.
Reports of Major Impact www.ajog.org Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population Kypros H. Nicolaides, MD; Argyro Syngelaki, RM; Ghalia Ashoor, MD;
Non-Invasive Prenatal Testing (NIPT) Factsheet
Introduction NIPT, which analyzes cell-free fetal DNA circulating in maternal blood, is a new option in the prenatal screening and testing paradigm for trisomy 21 and a few other fetal chromosomal aneuploidies.
fi АУ : fi apple Ав Ав АУ . apple, АУ fiав Ав. АК applefi АУ, АУАв Ав fi АУ apple fi Ав. А applefi АУ АУ АУ АсА» Ас Ам, длappleapple Ас...
АВАВАКдлАмА дла длама АсАядлАмА АВА АсдлАя & MАядлдлАмАК TА. 4, T. 2, АВ. 113-118, 2005 fi АУ : Аяapplefi. fiapple АсА» Ас Ам, длappleapple Ас..., Ая: Аяapplefi. fiapple, АВАУ Ас, АсА» Ас Ам длappleapple
Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers
DOI: 10.1002/pd.4019 ORIGINAL ARTICLE Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers Kevin Spencer* and Nicholas J. Cowans
The 11 13 +6 weeks scan
The 11 13 +6 weeks scan Kypros H. Nicolaides The 11 13 +6 weeks scan Fetal Medicine Foundation, London 2004 Dedication to Herodotos & Despina Contents Introduction 1. First trimester diagnosis of chromosomal
Fetal size and dating: charts recommended for clinical obstetric practice
Fetal size and dating: charts recommended for clinical obstetric practice Pam Loughna 1, Lyn Chitty 2, Tony Evans 3 & Trish Chudleigh 4 1 Academic Division of Obstetrics and Gynaecology, Nottingham University
First Trimester Screening for Down Syndrome
First Trimester Screening for Down Syndrome What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test
Charts of fetal size: limb bones
BJOG: an International Journal of Obstetrics and Gynaecology August 2002, Vol. 109, pp. 919 929 Charts of fetal size: limb bones Lyn S. Chitty a, *, Douglas G. Altman b Objective To construct new size
Gutenberg Center in MALAGA
Introduction Gutenberg Center in MALAGA Gutenberg Center in Málaga opened in 1987 as a clinic to provide integral assisstance for women, divided into 6 Units, specialized in the different aspects of Obs
Long-Term Prognosis of Pregnancies Complicated by Slow Embryonic Heart Rates in the Early First Trimester
Long-Term Prognosis of Pregnancies Complicated by Slow Embryonic Heart Rates in the Early First Trimester Peter M. Doubilet, MD, PhD, Carol B. Benson, MD, Jeanne S. Chow, MD Slow embryonic heart rates
Embryonic Heart Rate as a Prognostic Factor for Chromosomal Abnormalities
CME Article Embryonic Heart Rate as a Prognostic Factor for Chromosomal Abnormalities Deniz Oztekin, MD, Ozgur Oztekin, MD, Fatma I. Aydal, MD, Sivekar Tinar, MD, Zehra H. Adibelli, MD Objective. The purpose
Evaluation and Follow-up of Fetal Hydronephrosis
Evaluation and Follow-up of Fetal Hydronephrosis Deborah M. Feldman, MD, Marvalyn DeCambre, MD, Erin Kong, Adam Borgida, MD, Mujgan Jamil, MBBS, Patrick McKenna, MD, James F. X. Egan, MD Objective. To
The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands
FVV in ObGyn, 2014, 6 (1): 7-12 Preliminary report The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands P.J. Willems 1, H. Dierickx 1, ES. Vandenakker
Prenatal Testing Special tests for your baby during pregnancy
English April 2006 [OTH-7750] There are a number of different prenatal (before birth) tests to check the development of your baby. Each test has advantages and disadvantages. This information is for people
Ultrasonographic Diagnosis of Trisomy 18: Is It Practical in the Early Second Trimester?
Ultrasonographic Diagnosis of Trisomy 18: Is It Practical in the Early Second Trimester? Laurence E. Shields, MD, Leslie A. Carpenter, MS, CGC, Karin M. Smith, RDMS, Hanh V. Nghiem, MD The objective of
Ultrasonography of the Fetal Thyroid
Article Ultrasonography of the Fetal Thyroid Nomograms Based on Biparietal Diameter and Gestational Age Angela C. Ranzini, MD, Cande V. Ananth, PhD, MPH, John C. Smulian, MD, MPH, Michelle Kung, Anita
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although
Correspondence: Dr K. Spencer, Endocrine Unit, Clinical Biochemistry Department, Harold Wood Hospital, Gubbins Lane, Romford, Essex, RM3 0BE, UK
Ultrasound Obstet Gynecol 1999;:231 237 A screening program for trisomy 21 at 10 14 using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-a
Clinical Significance of First Trimester Umbilical Cord Cysts
Clinical Significance of First Trimester Umbilical Cord Cysts Waldo Sepulveda, MD, Sergio Leible, MD, Angel Ulloa, MD, Milenko Ivankovic, MD, Carlos Schnapp, MD A cystic mass of the umbilical cord was
Prognosis of Very Large First-Trimester Hematomas
Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate
Sonographic Accuracy of Estimated Fetal Weight in Twins
ORIGINAL RESEARCH Sonographic Accuracy of Estimated Fetal Weight in Twins Lorie M. Harper, MD, MSCI, Kimberly A. Roehl, MPH, Methodius G. Tuuli, MD, MPH, Anthony O. Odibo, MD, MSCE, Alison G. Cahill, MD,
Risk Calculation Software Requirements for Down's Syndrome Screening
Screening Programmes Fetal Anomaly Risk Calculation Software Requirements for Down's Syndrome Screening Version 1 January 2013 Created by: Dave Wright, Barry Nix, Steve Turner, David Worthington and Andy
Obstetrical Ultrasound and Prenatal Diagnostic Center
Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of
Non-invasive prenatal detection of chromosome aneuploidies using next generation sequencing: First steps towards clinical application
Non-invasive prenatal detection of chromosome aneuploidies using next generation sequencing: First steps towards clinical application PD Dr. rer. nat. Markus Stumm Zentrum für Pränataldiagnostik Kudamm-199
The California Prenatal Screening Program
The California Prenatal Screening Program Provider ook netic Disease Screening Program Quad Marker Screening Serum Integrated Screening Full Integrated Screening TABLE OF CONTENTS WELCOME to the California
The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report
0 The National Down Syndrome Cytogenetic Register for England and Wales: 2008/9 Annual Report Joan K Morris, Elizabeth De Souza December 2009 National Down Syndrome Cytogenetic Register Queen Mary University
Current Status in Non-Invasive Prenatal Detection of Down Syndrome, Trisomy 18, and Trisomy 13 Using Cell-Free DNA in Maternal Plasma
No. 287, February 2013 Current Status in Non-Invasive Prenatal Detection of Down Syndrome, Trisomy 18, and Trisomy 13 Using Cell-Free DNA in Maternal Plasma This committee opinion has been prepared by
Sequencing-based Tests to Determine Trisomy 21 from Maternal Plasma DNA
Sequencing-based Tests to Determine Trisomy 21 from Maternal Plasma DNA Policy Number: Original Effective Date: MM.03.006 09/01/2013 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 09/01/2013
School of Diagnostic Medical Sonography
Semester 1 Orientation - 101 This class is an introduction to sonography which includes a basic anatomy review, introduction to sonographic scanning techniques and physical principles. This curriculum
Down s Syndrome: Ultrasound Screening
October 2001 Down s Syndrome: Ultrasound Screening Hilary Hochberg Advanced Radiology Clerkship Dr. Gillian Lieberman Patient M.C. 32 year old female presents at 16 weeks gestational age with abnormal
11 13 +6 Weeks Scan Project Newsletter
USA FETAL MEDICINE FOUNDATION OF THE UNITED STATES OF A MERICA Non-profit Registration No.1635069 July 2007 11 13 +6 Weeks Scan Project Naomi Greene MPH RDMS RDCS 3940 Laurel Canyon Blvd. #838 Studio City,
3D Ultrasound. Outline. What is 3D US? Volume Sonography. 3D Ultrasound in Obstetrics: Current Modalities & Future Potential. Alfred Abuhamad, M.D.
in Obstetrics: Current Modalities & Future Potential Outline What is 3D US? What are obvious advantages of 3D US? What is the future of 3D US? Alfred Abuhamad, M.D. Eastern Virginia Medical School 2D US
Fetal echocardiography at 11 13 weeks by transabdominal high-frequency ultrasound
Ultrasound Obstet Gynecol 2011; 37: 296 301 Published online 10 February 2011 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.8934 Fetal echocardiography at 11 13 weeks by transabdominal
SWISS SOCIETY OF NEONATOLOGY. Umbilical cord complications in two subsequent pregnancies
SWISS SOCIETY OF NEONATOLOGY Umbilical cord complications in two subsequent pregnancies June 2006 2 Hetzel PG, Godi E, Bührer C, Department of Neonatology (HPG, BC), University Children s Hospital, Basel,
Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies
Ultrasound Obstet Gynecol 2013; 42: 34 40 Published online 7 June 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.12504 Implementation of maternal blood cell-free DNA testing in
Prenatal screening and diagnostic tests
Prenatal screening and diagnostic tests Contents Introduction 3 First trimester routine tests in the mother 3 Testing for health conditions in the baby 4 Why would you have a prenatal test? 6 What are
A test your patients can trust. A company you know and trust.
A test your patients can trust. A company you know and trust. informaseq Prenatal Test an advanced, non-invasive, prenatal screening for T21, T18, and T13 chromosomal aneuploidies using next generation
A Guide to Prenatal Genetic Testing
Patient Education Page 29 A Guide to Prenatal Genetic Testing This section describes prenatal tests that give information about your baby s health. It is your choice whether or not to have these tests
Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell- Free Fetal DNA
Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell- Free Fetal DNA Policy Number: Original Effective Date: MM.03.006 09/01/2013 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
Birth defects. Report by the Secretariat
EXECUTIVE BOARD EB126/10 126th Session 3 December 2009 Provisional agenda item 4.7 Birth defects Report by the Secretariat 1. In May 2009 the Executive Board at its 125th session considered an agenda item
Parvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Pack Parvovirus B19 Infection in Pregnancy Information Booklet CONTENTS: THE VIRUS page 3 CLINICAL MANIFESTATIONS page 6 DIAGNOSIS page 8 PATIENT MANAGEMENT
Estimation of Fetal Weight: Mean Value from Multiple Formulas
Estimation of Fetal Weight: Mean Value from Multiple Formulas Michael G. Pinette, MD, Yuqun Pan, MD, Sheila G. Pinette, RPA-C, Jacquelyn Blackstone, DO, John Garrett, Angelina Cartin Mean fetal weight
Department of Obstetrics and Gynecology, Kayseri Military Hospital, Kayseri, Turkey
Orıgınal Article Obstetrics & Gynecology North Clin Istanbul 2015;2(2):92-100 doi: 10.14744/nci.2015.08370 A prospective study to assess the clinical impact of interobserver reliability of sonographic
Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins
Article Effect of Increased Body Mass Index on the Accuracy of Estimated Fetal Weight by Sonography in Twins Manisha Gandhi, MD, Lauren Ferrara, MD, Victoria Belogolovkin, MD, Erin Moshier, MS, Andrei
Executive summary. Current prenatal screening
Executive summary Health Council of the Netherlands. NIPT: dynamics and ethics of prenatal screening. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/34. In recent years, new tests
Patient information on soft markers
Patient information on soft markers Before you read this section remember the following important points. The vast majority of babies with soft markers are normal. Soft markers are frequently seen in healthy
The California Prenatal Screening Program
The California Prenatal Screening Program Quad Marker Screening One blood specimen drawn at 15 weeks - 20 weeks of pregnancy (second trimester) Serum Integrated Screening Prenatal Patient Booklet - English
echocardiography practice and try to determine the ability of each primary indication to identify congenital heart disease. Patients and Methods
29 ABNORMAL CARDIAC FINDINGS IN PRENATAL SONOGRAPHIC EXAMINATION: AN IMPORTANT INDICATION FOR FETAL ECHOCARDIOGRAPHY? RIMA SAMI BADER Aim: The present study was conducted to evaluate the most common indications
Fetal Prognosis in Varix of the Intrafetal Umbilical Vein
Fetal Prognosis in Varix of the Intrafetal Umbilical Vein Waldo Sepulveda, MD, Antonio Mackenna, MD, Jorge Sanchez, MD, Edgardo Corral, MD, Eduardo Carstens, MD To assess the clinical significance of varix
REPRODUCTIVE ENDOCRINOLOGY
FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY
Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDIX HISTORY Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions
BELIEVE MIDWIFERY SERVICES, LLC
, LLC TITLE: ESTABLISHING the GESTATIONAL AGE & ROUTINE ULTRASOUND EFFECTIVE DATE: November 11th, 2013 POLICY STATEMENT Establishing accurate pregnancy dating impacts the management of normal and abnormal
Placenta, Cord, & Fluid
, Cord, & Fluid Abruption Accreta/Increta/Percreta Chorioangioma Complete Partial Not generally Relevant to U/S Gestational Age (Weeks) Distance from 16-23.9 24 to Internal Os >20 mm No No 11-20 mm 0-10
Fetal Lateral Ventricular Width: What Should Be Its Upper Limit?
Article Fetal Lateral Ventricular Width: What Should Be Its Upper Limit? A Prospective Cohort Study and Reanalysis of the Current and Previous Data Benny Almog, MD, Ronni Gamzu, MD, PhD, Reuven Achiron,
Trisomies 13 and 18. -Maternal age. (Patau and Edward s syndrome)
Trisomies 13 and 18 (Patau and Edward s syndrome) Trisomy 21 (Down syndrome) is the commonest chromosomal disorder at birth, and has been considered in detail in previous annual reports 23. Other relatively
THE USE OF FIRST TRIMESTER ULTRASOUND
SOGC CLINICAL PRACTICE GUIDELINES THE USE OF FIRST TRIMESTER ULTRASOUND This guideline has been reviewed by the Diagnostic Imaging Committee and approved by the Executive and Council of the Society of
CONGENITAL HEART DISEASE
CONGENITAL HEART DISEASE Introduction Congenital heart disease (CHD) is the most common congenital disorder in newborns [1]. Due to definitional issues, there are large variations in prevalence estimates.
Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, United States
78 Four Dimensional Fetal Echocardiography, 2010, 78-83 CHAPTER 9 Automated Echocardiography Elena Sinkovskaya and Alfred Abuhamad Department of Obstetrics and Gynecology, Eastern Virginia Medical School,
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method Ghalia ASHOOR 1, Argyro SYNGELAKI 1, Eric WANG 2, Craig STRUBLE 2, Arnold OLIPHANT 2,
Genetics and Pregnancy Loss
Genetics and Pregnancy Loss Dorothy Warburton Genetics and Development (in Pediatrics) Columbia University, New York Estimates of Pregnancy Loss from Conception 1000 fertilized eggs (27% are lost) 728
In most developed countries, prenatal screening
Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing Diana W. Bianchi, MD, Lawrence D. Platt, MD, James D. Goldberg, MD, Alfred Z. Abuhamad, MD, Amy J. Sehnert, MD, and Richard P. Rava,
INTERGROWTH-21 st International Fetal and Newborn Growth Standards for the 21 st Century
INTERGROWTH-21 st CRL standardization 1 INTERGROWTH-21 st International Fetal and Newborn Growth Standards for the 21 st Century The International Fetal and Newborn Growth Consortium Correct measurement
RECURRENT PREGNANCY LOSS DR.RAJALAKSHMI SRINIVASAN SPECIALIST GYNECOLOGIST ZULEKHA HOSPITAL DUBAI
RECURRENT PREGNANCY LOSS DR.RAJALAKSHMI SRINIVASAN SPECIALIST GYNECOLOGIST ZULEKHA HOSPITAL DUBAI RECURRENT PREGNANCY LOSS -RM Clinically recognized consecutive or non consecutive pregnancy losses before
First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI
Ultrasound Obstet Gynecol 2009; 33: 8 17 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.6254 First-trimester screening markers are altered in pregnancies conceived
The ultrasound detection of chromosomal anomalies 1
The ultrasound detection of chromosomal anomalies 1 Werther Adrian Clavelli, MD 2, Silvia Susana Romaris de Clavelli, MD 2, Philippe Jeanty, MD, PhD 3 Adapted from The Ultrasound Detection of Chromosomal
Umbilical Artery Doppler Waveform Indices in Normal Pregnancies
Thai Journal of Obstetrics and Gynaecology June 2000, Vol. 12, pp. 103-107 OBSTETRICS Umbilical Artery Doppler Waveform Indices in Normal Pregnancies Pharuhas Chanprapaph MD, Chanane Wanapirak MD, Theera
CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA
CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Cytogenetics is the study of chromosomes and their structure, inheritance, and abnormalities. Chromosome abnormalities occur in approximately:
GE Healthcare VOLUSON 730 PRO The Diamond Release
GE Healthcare VOLUSON 730 PRO The Diamond Release imagination at work VOLUSON 730 PRO The Standard in Women's Healthcare 4D Dedication Dimensional Diagnostic Digital GE Healthcare continues to elevate
IBGRL, NHSBT, Bristol
IBGRL, NHSBT, Bristol Valuable to know D type of fetus Fetus D-positive: at risk pregnancy should be managed appropriately Fetus D-negative: not at risk no need for intervention RHD RHCE RHD* D 37 bp
First- and Second-Trimester Evaluation of Risk for Down Syndrome
Original Research First- and Second-Trimester Evaluation of Risk for Down Syndrome Robert H. Ball, MD, Aaron B. Caughey, MD, MPP, Fergal D. Malone, MD, David A. Nyberg, MD, Christine H. Comstock, MD, George
What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy?
What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy? Full citation Sample size Tests Methods Results Limitations Steinkampf,M.P., Guzick,D.S., Hammond,K.R., Blackwell,R.E.,
Complimentary and personal copy for
Complimentary and personal copy for www.thieme.com Publishing House and Copyright: 2015 by Georg Thieme Verlag KG Rüdigerstraße 14 70469 Stuttgart ISSN Any further use only by permission of the Publishing
Position Statement from the Aneuploidy Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis, April 2013
Position Statement from the Aneuploidy Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis, April 2013 Peter Benn (Chair), Antoni Borell, Rossa Chiu, Howard Cuckle,
Reference values for umbilical cord diameters in placenta specimens
1 2 3 Reference values for umbilical cord diameters in placenta specimens H. Pinar 1, Murat Iyigün 2 4 5 6 7 8 9 10 Halit Pinar, MD Brown Medical School Women and Infants Hospital Division of Perinatal
Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood
Clinical Chemistry 57:7 1042 1049 (2011) Molecular Diagnostics and Genetics Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal
Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment
Original Article Ann Clin Biochem 2001; 38: 230±234 Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment S N Millner From the Department of Pathology, University of
